Kangtai Biological
Overview
Shenzhen Kangtai Biological Products Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of human vaccines in China and internationally. The company offers 13-valent pneumococcal polysaccharide conjugate vaccines (TT/DT); varicella vaccines (freeze-dried); hepatitis B vaccines; 23-valent pneumococcal polysaccharide vaccines; diphtheria tetanus acellular pertussis and haemophilus influenzae type B combined vaccines; diphtheria, tetanus, and acellu
Employees1957
Market Cap$13.2B
Revenue$2.7B
Listed OnShenzhen Stock Exchange
Ticker300601
CEOMr. Xiang Miao
HeadquartersShenzhen